Carlo Andrea Bravi
Onze Lieve Vrouwziekenhuis Hospital, Vita-Salute San Raffaele University, Memorial Sloan Kettering Cancer Center, IRCCS Ospedale San Raffaele, ORSI Academy, Royal Marsden NHS Foundation Trust, Apple (Israel), Istituti di Ricovero e Cura a Carattere Scientifico, Northampton General Hospital
Papers
59
Total Citations
1,498
H-Index
19
About
Carlo Andrea Bravi is a prominent urological surgeon and researcher whose work sits at the intersection of robotic surgery, minimally invasive urology, and surgical oncology. His research has fundamentally advanced the field of robot-assisted radical prostatectomy, with particular focus on optimizing surgical techniques, evaluating emerging robotic platforms, and understanding the learning curves that shape oncological outcomes. Bravi has been a leading voice in the comparative assessment of robotic systems, producing some of the earliest and most widely cited evidence on the Hugo RAS surgical system — a novel platform challenging the long-standing dominance of the da Vinci robot — with related publications accumulating over 300 citations combined. His multicenter work on partial nephrectomy outcomes, part of the RECORd 2 Project, further demonstrates his commitment to large-scale, real-world evidence in urological surgery. Notably, his investigations into surgical margins and biochemical recurrence have provided surgeons with actionable insights into how experience translates into improved cancer control. Across his most-cited publications alone, Bravi's work has garnered nearly 1,000 citations, reflecting his substantial influence on contemporary urological surgical practice and training worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy124 citations · 2020
- 4
- 5Potential Contenders for the Leadership in Robotic Surgery89 citations · 2021
- 6
- 7
- 8
- 9
- 10